Macquarie Group’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-308
| Closed | -$20K | – | 1662 |
|
|
2024
Q3 | $20K | Sell |
308
-438,022
| -100% | -$31.6M | ﹤0.01% | 1611 |
|
|
2024
Q2 | $29.6M | Buy |
438,330
+59,571
| +16% | +$4.16M | 0.03% | 570 |
|
|
2024
Q1 | $30M | Sell |
378,759
-26,850
| -7% | -$2.2M | 0.03% | 586 |
|
|
2023
Q4 | $31.5M | Sell |
405,609
-36,940
| -8% | -$2.73M | 0.04% | 573 |
|
|
2023
Q3 | $31.1M | Sell |
442,549
-76,507
| -15% | -$5.72M | 0.04% | 546 |
|
|
2023
Q2 | $41.3M | Buy |
519,056
+25,570
| +5% | +$1.85M | 0.05% | 488 |
|
|
2023
Q1 | $35.7M | Buy |
493,486
+440,221
| +826% | +$34.3M | 0.04% | 529 |
|
|
2022
Q4 | $4.38M | Sell |
53,265
-263,745
| -83% | -$21.7M | 0.01% | 1010 |
|
|
2022
Q3 | $24.9M | Buy |
317,010
+219,734
| +226% | +$17.6M | 0.03% | 633 |
|
|
2022
Q2 | $6.58M | Buy |
97,276
+95,444
| +5,210% | +$6.66M | 0.01% | 969 |
|
|
2022
Q1 | $120 | Sell |
1,832
-1,758
| -49% | -$102K | ﹤0.01% | 1904 |
|
|
2021
Q4 | $218K | Buy |
3,590
+58
| +2% | +$3.46K | ﹤0.01% | 1745 |
|
|
2021
Q3 | $225K | Sell |
3,532
-355
| -9% | -$22.4K | ﹤0.01% | 1784 |
|
|
2021
Q2 | $244K | Sell |
3,887
-1,211
| -24% | -$75.9K | ﹤0.01% | 1771 |
|
|
2021
Q1 | $291K | Sell |
5,098
-1,133
| -18% | -$61.3K | ﹤0.01% | 1623 |
|
|
2020
Q4 | $313K | Sell |
6,231
-985
| -14% | -$39.3K | ﹤0.01% | 1549 |
|
|
2020
Q3 | $213K | Sell |
7,216
-346
| -5% | -$10K | ﹤0.01% | 1597 |
|
|
2020
Q2 | $190K | Buy |
7,562
+2,940
| +64% | +$73.4K | ﹤0.01% | 1561 |
|
|
2020
Q1 | $85K | Sell |
4,622
-2,931
| -39% | -$83.9K | ﹤0.01% | 1675 |
|
|
2019
Q4 | $251K | Buy |
+7,553
| New | +$237K | ﹤0.01% | 1541 |
|
|
2018
Q1 | – | Sell |
-37,540
| Closed | -$1.23M | – | 2150 |
|
|
2017
Q4 | $1.23M | Buy |
37,540
+16,540
| +79% | +$573K | ﹤0.01% | 1187 |
|
|
2017
Q3 | $1M | Buy |
+21,000
| New | +$1.02M | ﹤0.01% | 1209 |
|
|
2017
Q2 | – | Sell |
-43,290
| Closed | -$1.89M | – | 1520 |
|
|
2017
Q1 | $1.89M | Sell |
43,290
-39,990
| -48% | -$1.62M | ﹤0.01% | 991 |
|
|
2016
Q4 | $2.76M | Buy |
83,280
+52,690
| +172% | +$2.04M | 0.01% | 879 |
|
|
2016
Q3 | $1.52M | Sell |
30,590
-62,678
| -67% | -$3.26M | ﹤0.01% | 1037 |
|
|
2016
Q2 | $5.17M | Sell |
93,268
-4,277
| -4% | -$250K | 0.01% | 865 |
|
|
2016
Q1 | $5.38M | Buy |
97,545
+51,827
| +113% | +$2.96M | 0.01% | 696 |
|
|
2015
Q4 | $2.86M | Sell |
45,718
-772
| -2% | -$50.3K | 0.01% | 840 |
|
|
2015
Q3 | $3.08M | Sell |
46,490
-10,145
| -18% | -$780K | 0.01% | 862 |
|
|
2015
Q2 | $4.44M | Sell |
56,635
-7,752
| -12% | -$558K | 0.01% | 780 |
|
|
2015
Q1 | $4.61M | Buy |
64,387
+7,335
| +13% | +$470K | 0.01% | 768 |
|
|
2014
Q4 | $3.49M | Sell |
57,052
-9,445
| -14% | -$550K | 0.01% | 836 |
|
|
2014
Q3 | $3.23M | Hold |
66,497
| – | – | 0.01% | 845 |
|
|
2014
Q2 | $3.03M | Buy |
66,497
+29,031
| +77% | +$1.28M | 0.01% | 883 |
|
|
2014
Q1 | $1.69M | Sell |
37,466
-6,852
| -15% | -$338K | ﹤0.01% | 1059 |
|
|
2013
Q4 | $2.1M | Buy |
44,318
+3,671
| +9% | +$160K | ﹤0.01% | 967 |
|
|
2013
Q3 | $1.6M | Buy |
40,647
+2,370
| +6% | +$88K | ﹤0.01% | 1032 |
|
|
2013
Q2 | $1.27M | Buy |
+38,277
| New | +$1.24M | ﹤0.01% | 1089 |
|
Other funds holding ACHC
PCP
MAP
Macquarie Group's ACHC Position: Q4 2024 in Review
Macquarie Group sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 308 shares — an estimated $20K sold.
Macquarie Group first reported a position in ACHC in Q2 2013 and held it in 38 quarters. The position peaked at $41.3M in Q2 2023. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.
- Macquarie Group reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
- Macquarie Group sold 308 Acadia Healthcare shares in Q4 2024, an estimated $20K.
- Macquarie Group first reported a position in Acadia Healthcare in Q2 2013 and held it in 38 quarters.
- Macquarie Group's Acadia Healthcare position peaked at $41.3M in Q2 2023.
- 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.
Based on Macquarie Group's 13F filing for Q4 2024, filed 14 Feb 2025.